High-dose therapy and transplantation for low-grade lymphoma

Hematology/Oncology Clinics of North America

Volumn 11, Issue 5, 1997, Pages 919-935

  Horning, S J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; FOLLOW UP; HUMAN; LYMPHOMA; MINIMAL RESIDUAL DISEASE; MYELODYSPLASIA; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0030885216     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70470-6     Document Type: Article

References (38)

1. Y. Bastion P. Brice C. Haioun Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma Blood 86 1995 3257
2. P.J. Bierman J.M. Vose J.R. Anderson High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma J Clin Oncol 15 1997 445
3. F. Cervantes X.O. Shu P.B. McGlave Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma Bone Marrow Transplant 16 1995 387
4. N.J. Chao A.P. Nademanee G.D. Long Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease J Clin Oncol 9 1991 1575
5. P. Colombat D. Donadio L. Fouillard Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients Bone Marrow Transplant 13 1994 157
6. D.L. Darrington J.M. Vose J.R. Anderson Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 12 1994 2527
7. L. Fouillard N.C. Gorin J.P. Laporte Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma Eur J Haematol 46 1991 279
8. A.S. Freedman J.G. Gribben D. Neuberg High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission Blood 88 1996 2524
9. A.S. Freedman J. Ritz D. Neuberg Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma Blood 77 1991 2780
10. M.K. Gospodarowicz S.B. Sutcliffe W.A. Wells Results of involved field radiotherapy in clinical stage I–II low grade lymphoma Int J Radiat Oncol Biol Phys 24 1992 227
11. R. Govindarajan S. Jagannath J.T. Flick Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma Br J Haematol 95 1996 349
12. J.G. Gribben A.S. Freedman D. Neuberg Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma N Engl J Med 325 1991 1525
13. J.G. Gribben D. Neuberg A.S. Freedman Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma Blood 81 1993 3449
14. Gribben JG, Anderson NS, Freedman AS, et al: Molecular characterization of secondary non-Hodgkin's lymphomas occurring after ABMT for lymphoma [abstract 2709]. In Programs and Abstracts of the 38th Annual Meeting of the American Society of Hematology, Orlando, 1996, p 680
15. R. Haas M. Moos R. Mohle High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma Bone Marrow Transplant 17 1996 149
16. R.T. Hoppe P. Kushlan H.S. Kaplan The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: A preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation Blood 58 1981 592
17. S.J. Horning Natural history of and therapy for the indolent non-Hodgkin's lymphomas Semin Oncol 20 1993 75
18. P.W. Johnson C.G. Price T. Smith Detection of cells bearing the t(14,18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma J Clin Oncol 12 1994 798
19. P.W. Johnson A.Z. Rohatiner J.S. Whelan Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center J Clin Oncol 13 1995 140
20. T.S. Lawrence W.J. Urba S.M. Steinberg Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute Int J Radiat Oncol Biol Phys 14 1988 417
21. J. Limpens D. de Jong J.H. van Krieken Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia Oncogene 6 1991 2271
22. J. Limpens R. Stad C. Vos Lymphoma-associated translocation t(14,18) in blood B cells of normal individuals Blood 85 1995 2528
23. M.P. MacManus R.T. Hoppe Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University J Clin Oncol 14 1996 1282
24. J.S. Miller D.C. Arthur C.E. Litz Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy Blood 83 1994 3780
25. P. Morel J.P. Laporte M.P. Noel Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: A pilot study of 34 cases Leukemia 9 1995 976
26. T. Philip C. Guglielmi A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540
27. C.G. Price J. Meerabux S. Murtagh The significance of circulating cells carrying t(14,18) in long remission from follicular lymphoma J Clin Oncol 9 1991 1527
28. A.Z. Rohatiner P.W. Johnson C.G. Price Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma J Clin Oncol 12 1994 1177
29. Solal-Celigny P, Lepage E, Brousse N, et al: A doxorubicin containing regimen with or without interferon alpha 2 b (IFNa 2b) in advanced follicular lymphomas. Final analysis of survival, toxicity and quality of life of the GELF86 trial [abstract 1800]. In Programs and Abstracts of the 38th Annual Meeting of the American Society of Hematology, Orlando, 1996, p 453
30. R.M. Stone D. Neuberg R. Soiffer Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 12 1994 2535
31. S.T. Traweek M.L. Slovak A.P. Nademanee Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma Blood 84 1994 957
32. Unterhalt M, Hermann R, Koch P, et al: Long term interferon alpha maintenance prolongs remission duration in advanced low grade lymphomas and is related to the efficacy of initial cytoreductive chemotherapy [abstract 1801]. In Programs and Abstracts of the 38th Annual Meeting of the American Society of Hematology, Orlando, 1996, p 453
33. K.W. van Besien I.F. Khouri S.A. Giralt Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: The case for aggressive management J Clin Oncol 13 1995 1096
34. K.W. van Besien R.C. Mehra S.A. Giralt Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity and survival depend on disease histology Am J Med 100 1996 299
35. K.W. van Besien P.A. Rowlings K.A. Sobocinski Allogeneic bone marrow transplantation (BMT) for low grade lymphoma [abstract 1263] Proc ASCO, Los Angeles 1995 401
36. D.J. Weisdorf J.W. Andersen J.H. Glick Survival after relapse of low-grade non-Hodgkin's lymphoma: Implications for marrow transplantation J Clin Oncol 10 1992 942
37. C.D. Williams A.H. Goldstone R.M. Pearce Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry J Clin Oncol 14 1996 2454
38. C.S. Zwicky A.B. Maddocks N. Andersen Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation Blood 88 1996 3314